Latigo Biotherapeutics Inc.(LTGO)

Medical - Pharmaceuticals · Thousand Oak, CA

$16.26-0.37 (-2.22%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T20:42:09.981Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:42:09.981Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 978,090,886
TTM free cash flow: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LTGO Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

LTGO Competitors' Price/FCF Ratio

LTGO

Latigo Biotherapeutics Inc.

Current

Market Cap

$978.09M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGTX

MeiraGTx Holdings plc

vs LTGO

Market Cap

$981.66M

Price/FCF Ratio

N/A

TTM Avg

31.06

3Y Avg

31.06

5Y Avg

31.06

PCRX

Pacira BioSciences, Inc.

vs LTGO

Market Cap

$973.93M

Price/FCF Ratio

5.43

TTM Avg

7.51

3Y Avg

7.85

5Y Avg

14.47

LBRX

LB Pharmaceuticals Inc Common Stock

vs LTGO

Market Cap

$982.46M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VOR

Vor Biopharma Inc.

vs LTGO

Market Cap

$992.14M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRCT

PROCEPT BioRobotics Corporation

vs LTGO

Market Cap

$996.65M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGEM

Cullinan Therapeutics, Inc.

vs LTGO

Market Cap

$998.69M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AKTS

Aktis Oncology, Inc.

vs LTGO

Market Cap

$953.81M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SVRA

Savara Inc.

vs LTGO

Market Cap

$952.91M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMTX

Immatics N.V.

vs LTGO

Market Cap

$1.01B

Price/FCF Ratio

N/A

TTM Avg

6.28

3Y Avg

5.25

5Y Avg

24.15

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Latigo Biotherapeutics Inc. (LTGO)	$978.09M	N/A	N/A	N/A	N/A
MeiraGTx Holdings plc (MGTX)vs ›	$981.66M	N/A	31.06	31.06	31.06
Pacira BioSciences, Inc. (PCRX)vs ›	$973.93M	5.43	7.51	7.85	14.47
LB Pharmaceuticals Inc Common Stock (LBRX)vs ›	$982.46M	N/A	N/A	N/A	N/A
Vor Biopharma Inc. (VOR)vs ›	$992.14M	N/A	N/A	N/A	N/A
PROCEPT BioRobotics Corporation (PRCT)vs ›	$996.65M	N/A	N/A	N/A	N/A
Cullinan Therapeutics, Inc. (CGEM)vs ›	$998.69M	N/A	N/A	N/A	N/A
Aktis Oncology, Inc. (AKTS)vs ›	$953.81M	N/A	N/A	N/A	N/A
Savara Inc. (SVRA)vs ›	$952.91M	N/A	N/A	N/A	N/A
Immatics N.V. (IMTX)vs ›	$1.01B	N/A	6.28	5.25	24.15

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

LTGO Price/FCF Ratio Metrics

LTGO Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics